Exploring New Frontiers in Hepatocellular Carcinoma Treatment: Insights from the CheckMate 9DW Trial

In our latest “Ask the Author” session, Professor Peter Galle presented the groundbreaking results of the CheckMate 9DW clinical trial, which explored the efficacy of the combination of nivolumab and ipilimumab versus lenvatinib or sorafenib as first-line treatments for unresectable hepatocellular carcinoma (HCC). Below you will find the video as well as the summary: Background:

Read more >

Reimagining Hepatocellular Carcinoma Treatment: Insights from Professor Vitale

In a recent “Ask the Author” session, we had the pleasure of hosting Professor Vitale from the University of Padova, Italy. Renowned for his contributions to the field of hepatocellular carcinoma (HCC), Professor Vitale discussed his latest publication, “Merits and Boundaries of the BCLC Staging and Treatment Algorithm: Learning From the Past to Improve the

Read more >

HCC Day 2024 quick recap

Prof. Jean-François Dufour co-organized the HCC Day 2024 related to Liver Cancer treatments end of February in Bern, Switzerland. In this short video summary, he briefly recaps the 6 lectures given by world-wide Key Opinion Leaders. If you are active in this medical field, it should be of high interest to you. All the videos

Read more >

Event

For the benefit of patients, we are organizing on December 5, 2019 in Lausanne the information day on Hepatocellular Carcinoma (HCC), bringing together the different specialties. Several European experts will discuss the latest diagnostic and therapeutic developments. HCC Update 2019

Read more >

Enter your email address to stay in touch with the Foundation